Epicutaneous Immunotherapy Shows Promise Against Peanut Allergy – Monthly Prescribing Reference (registration)
|
Epicutaneous Immunotherapy Shows Promise Against Peanut Allergy
Monthly Prescribing Reference (registration) ATLANTA, GA—Epicutaneous immunotherapy (EPIT) treatment of peanut allergy with Viaskin® Peanut (VP) shows long-term safety and efficacy, according to findings from a 2-year open-label extension phase of the VIPES Phase 2b study, presented at the … |
